+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Progeria Drug"

From
Progeria - Epidemiology Forecast - 2032 - Product Thumbnail Image

Progeria - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Progeria is a rare genetic disorder that causes accelerated aging in children. It is a part of the larger category of endocrine and metabolic disorders drugs. These drugs are used to treat a variety of conditions, including diabetes, obesity, and thyroid disorders. Progeria drugs are designed to slow the progression of the disease and improve the quality of life for those affected. The Progeria drug market is relatively small, but it is growing as more research is conducted and new treatments are developed. Companies in the market are focused on developing treatments that can slow the progression of the disease and improve the quality of life for those affected. Some of the companies in the market include Genentech, Novartis, and Pfizer. Show Less Read more